73.3336
92.3913
1
1 Lakh
Investment declined to₹ 10000
Monthly SIP Declined toSuitability:
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.
Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Taxability of earnings:
Capital gains
Dividends
Please wait...
Please wait...
| YTD | 1-Day | 1-W | 1-M | 3-M | 6-M | 1-Y | 3-Y | 5-Y | 7-Y | 10-Y | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ICICI Pru Healthcare ETF-G | -15.58 | 0.33 | 3.34 | -2.98 | -11.94 | -10.92 | -10.64 | -- | -- | -- | -- |
| S&P BSE Healthcare TRI | -17.11 | 0.60 | 3.15 | -3.22 | -11.43 | -12.70 | -12.12 | -- | -- | -- | -- |
| Equity: Sectoral-Pharma | -15.93 | 0.41 | 3.01 | -2.63 | -10.76 | -11.45 | -10.36 | -- | -- | -- | -- |
| Rank within category | 6 | 11 | 2 | 10 | 13 | 5 | 6 | -- | -- | -- | -- |
| Number of funds in category | 14 | 14 | 14 | 14 | 14 | 14 | 11 | 8 | 4 | 3 | 3 |
As on 24-Jun-2022
| Fund name | Rating | Launch Date | 1-Year Return | 3-Year Return | 5-Year Return | Expense Ratio | Assets (Cr) |
|---|---|---|---|---|---|---|---|
| ICICI Prudential Healthcare ETF | Invest Now | May-21 | -10.64 | -- | -- | 0.15% | 106 | |
| Nippon India Pharma Fund | Jun-04 | -12.37 | 23.27 | 15.47 | 1.95% | 4,516 | |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | Invest Now | Jul-18 | -10.28 | 23.78 | -- | 2.14% | 2,316 | |
| Mirae Asset Healthcare Fund - Regular Plan | Invest Online | Jul-18 | -7.16 | 26.62 | -- | 2.10% | 1,692 | |
| SBI Healthcare Opportunities Fund | Invest Online | Jul-99 | -10.49 | 23.11 | 10.06 | 2.13% | 1,638 |
| Best Performance | Worst Performance | |||
|---|---|---|---|---|
| Return (%) | Period | Return (%) | Period | |
| Week | 6.78 | 07-Mar-2022 - 14-Mar-2022 | -7.05 | 02-May-2022 - 10-May-2022 |
| Month | 9.16 | 07-Mar-2022 - 06-Apr-2022 | -10.86 | 12-Apr-2022 - 12-May-2022 |
| Quarter | 9.05 | 04-Jun-2021 - 03-Sep-2021 | -13.96 | 17-Mar-2022 - 17-Jun-2022 |
| Year | -5.28 | 21-May-2021 - 23-May-2022 | -13.98 | 17-Jun-2021 - 17-Jun-2022 |
| Mean | Std Dev | Sharpe | Sortino | Beta | Alpha | |
|---|---|---|---|---|---|---|
| ICICI Pru Healthcare ETF-G | -- | -- | -- | -- | -- | -- |
| S&P BSE Healthcare TRI* | 20.60 | 22.31 | 0.77 | 1.52 | -- | -- |
| Equity: Sectoral-Pharma* | 22.83 | 20.27 | 0.96 | 1.93 | 0.89 | 4.17 |
| Rank within category | -- | -- | -- | -- | -- | -- |
| Number of funds in category | -- | -- | -- | -- | -- | -- |
The Risk Measures have been calculated using calendar month returns for the last three years.
As on
* As on 31-May-2022
Please wait...
| Number of Stocks | 20 |
| Top 10 Stocks (%) | 82.20 |
| Top 5 Stocks (%) | 63.63 |
| Top 3 Sectors (%) | 99.99 |
| Portfolio P/B Ratio | 4.27 |
| Portfolio P/E Ratio | 37.14 |
| Fund | Category | |
|---|---|---|
| Average Mkt Cap (Rs Cr) | 65,254 | 55,629 |
| Giant (%) | 20.85 | 19.21 |
| Large (%) | 45.90 | 38.04 |
| Mid (%) | 31.46 | 35.58 |
| Small (%) | 1.79 | 7.07 |
| Tiny (%) | -- | 0.73 |
Please wait...
| Company | Sector | P/E | 3Y High | 3Y Low | % Assets | |
|---|---|---|---|---|---|---|
|
Sun Pharmaceutical Industries | Healthcare | 60.42 | 20.88 | 14.35 | 20.85 |
|
|
Dr. Reddy's Lab | Healthcare | 32.85 | 13.31 | 10.45 | 11.91 |
|
|
Cipla | Healthcare | 29.92 | 11.51 | 9.06 | 11.51 |
|
|
Divi's Laboratories | Healthcare | 32.92 | 13.67 | 10.26 | 10.26 |
|
|
Apollo Hospitals | Healthcare | 52.24 | 11.68 | 6.59 | 9.11 |
|
|
Laurus Labs | Healthcare | 30.30 | 5.31 | 4.07 | 4.99 |
|
|
Alkem Laboratories | Healthcare | 21.82 | 3.72 | 2.58 | 3.46 |
|
|
Biocon | Healthcare | 60.53 | 3.74 | 3.09 | 3.42 |
|
|
Aurobindo Pharma | Healthcare | 11.64 | 5.81 | 3.35 | 3.35 |
|
|
Lupin | Healthcare | -- | 6.07 | 3.34 | 3.34 |
|
|
Torrent Pharmaceuticals | Healthcare | 62.67 | 3.21 | 2.77 | 3.12 |
|
|
Ipca Laboratories | Healthcare | 25.44 | 3.32 | 2.73 | 2.77 |
|
|
Zydus Lifesciences | Healthcare | 8.06 | 3.28 | 1.84 | 2.17 |
|
|
Abbott India | Healthcare | 48.12 | 2.10 | 0.00 | 2.10 |
|
|
Dr. Lal Pathlabs | Healthcare | 49.11 | 2.51 | 1.52 | 1.52 |
|
|
Pfizer | Healthcare | 30.64 | 1.77 | 1.40 | 1.51 |
|
|
Syngene International | Healthcare | 57.56 | 1.51 | 0.00 | 1.49 |
|
|
Glenmark Pharma. | Healthcare | 11.48 | 1.92 | 1.32 | 1.32 |
|
|
Metropolis Healthcare | Healthcare | 34.29 | 1.75 | 0.00 | 0.93 |
|
|
Granules India | Healthcare | 15.44 | 0.97 | 0.00 | 0.86 |
Indicates an increase or decrease or no change in holding since last portfolio
Indicates a new holding since last portfolio
As on 31-May-2022
— Kayzad Eghlim since 06-May-2021
Education: Mr. Eghlim is a B.Com (H) and M Com.
Experience: Prior to joining ICICI Prudential AMC he has worked with IDFC Investment Advisors Ltd., Prime Securities and Canara Robeco Mutual Fund.
Funds Managed:
— Nishit Patel since 06-May-2021
Education: Mr. Patel is a B.Com & Chartered Accountant
Experience: ICICI Prudential Asset Management Company Limited - ETF Business - November 2018 - January 2020.
Funds Managed:
The scheme seeks to provide returns before expenses that closely correspond to the total return of the underlying index subject to tracking errors.
| Min. Investment (₹) | 1,000 |
| Min. Addl Investment (₹) | -- |
| Min. SIP Investment (₹) | -- |
| Min. No of Cheques | -- |
| Min. Withdrawal (₹) | -- |
| Min. Balance (₹) | -- |
| Lock-in Period | Not Applicable |
| Exit Load | 0 |
| Fund House: | ICICI Prudential Mutual Fund |
| Launch Date: | 19-May-2021 |
| Return Since Launch: | -8.75% |
| Benchmark: | NIFTY Healthcare TRI. |
| Riskometer: | Very High |
| Type: | Open-ended |
| Assets: | ₹ 106 Cr (As on 31-May-2022) |
| Expense: | 0.15% (As on 31-May-2022) |
| Risk Grade: | -- |
| Return Grade: | -- |
| Turnover: | 156.00% |
AMC: ICICI Prudential Asset Management Company Ltd
Address: One BKC , A Wing , 13th Floor, Bandra Kurla Complex, Mumbai - 400051
Fax: 022-26528100
Website: http://www.icicipruamc.com
Registrar & Transfer Agent: Computer Age Management Services Ltd.
Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002
Phone: 1800-3010-6767 / 1800-419-7676
Fax: 044-30407101
Email: [email protected]
Website: www.camsonline.com
You have reserved a spot
Fri, 01-Jul-2022
12:30 PM - 12:45 PM